Methods and compositions relating to Alzheimers disease are provided, including proteins that are differentially expressed in Alzheimers disease as compared to the normal state. Further provided are methods, particularly experimental paradigms, for the identification of differential expressed proteins that are potential molecular targets for compounds to treat or prevent Alzheimers disease. Also provided are methods for the identification and therapeutic use of compounds for the prevention and treatment of Alzheimers disease.
